PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Na,K-ATPase Antibody
#3010 · $317
100
Citing papers
18.4k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Immune cells in cancer
7
Genomics, phytochemicals, and oxidative stress
7
Immunotherapy and Immune Responses
6
PI3K/AKT/mTOR signaling in cancer
6
HER2/EGFR in Cancer Research
5
Adipose Tissue and Metabolism
5
Extracellular vesicles in disease
5
Immune Response and Inflammation
5
Papers citing this product
1
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Nature Communications
·
2016
·
1.8k cit.
·
DOI
2
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Blood
·
2009
·
641 cit.
·
DOI
3
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
Journal of Neuroinflammation
·
2020
·
601 cit.
·
DOI
4
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Nature Communications
·
2018
·
558 cit.
·
DOI
5
Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib
JNCI Journal of the National Cancer Institute
·
2005
·
467 cit.
·
DOI
6
Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism
Journal of Clinical Investigation
·
2006
·
436 cit.
·
DOI
7
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i>
Proceedings of the National Academy of Sciences
·
2012
·
436 cit.
·
DOI
8
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Nature
·
2018
·
415 cit.
·
DOI
9
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
Nature Communications
·
2017
·
409 cit.
·
DOI
10
Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid
Journal of Biological Chemistry
·
2005
·
388 cit.
·
DOI
Show 90 more papers
Feedback
Na,K-ATPase Antibody — Evidence — PubIndex